Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.
|Articles|September 1, 2002
- Volume 0 0
Insulin-Producing Stem Cells Created
Advertisement
Stem cells may hold the key to actually curing diabetes. As reported in Endocrinology (August 2002), researchers from Massachusetts General Hospital in Boston took human pancreas islet stem cells and exposed them to the hormone glucagon-like peptide-1 (GLP-1). That caused the islet stem cells to begin producing insulin. The notion is that transplanting insulin-producing cells from a person?s own stem cells will prevent rejection by the immune system. The investigators emphasize, however, that much more research is needed.
Articles in this issue
about 24 years ago
Seperate Powders??about 24 years ago
Pure testosterone isocaproate powder...about 24 years ago
Delivery of progesterone...about 24 years ago
Try a Little Exerciseabout 24 years ago
Seasonal Affective Disorderabout 24 years ago
Most Asthmatics Are Not Using Anti-inflammatory Drugsabout 24 years ago
New Guidelines on Inhaler Packaging Are Issuedabout 24 years ago
Big Babies Have Reduced Diabetes Riskabout 24 years ago
Niacin Therapyabout 24 years ago
Whole-Grain HealthAdvertisement
Related to this article
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
2
FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia
3
Pneumonic Plague: What Pharmacists Need to Know About Treatment
4
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
5